BENGALURU, India–(BUSINESS WIRE)–Nov. 13, 2024 STEERLife, a pioneer in pharmaceutical development technologies, and Callidus Research Laboratories, a formulation development services company with a wealth of experience in comprehensive pharmaceutical drug development, have forged a strategic partnership to accelerate drug development for global markets. STEERLife is a division of STEER World. The collaboration combines STEERLife's advanced […]
Category: Biomedical
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment
NEW YORK–(BUSINESS WIRE)–Nov. 13, 2024 Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a leader in Everest Group's first-ever Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment 2024. The report assessed 13 providers based on the market impact of […]
Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials
Expanded collaboration leverages Clinical Data Studio and AI-driven biometrics to deliver high-quality, efficient data services for Bioforum’s client LONDON–(BUSINESS WIRE)–Nov. 12, 2024 Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new enterprise agreement with Bioforum, a biometrics CRO that serves clinical trial sponsors […]
Singapore’s National Precision Medicine (NPM) Programme Engages Oxford Nanopore to Advance Understanding of the Genetics of Singapore’s Multi-Ethnic Population
Singapore’s National Precision Medicine (NPM) programme will sequence 10,000 genomes to improve understanding of genetic architecture and diversity in Singapore’s multi-ethnic Asia population through advanced, nanopore-based sequencing technology OXFORD, England–(BUSINESS WIRE)–Aug. 05, 2024 Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme, led by Precision Health Research, […]
Medisca Opens New Pharmaceutical Repackaging Facility to Meet Global Demands in Personalized Medicine
PLATTSBURGH, N.Y.–(BUSINESS WIRE)–Jun. 27, 2024 Medisca, a global leader in personalized pharmaceutical solutions, held a grand opening event on June 20, 2024, for their new repackaging and distribution facility in Plattsburgh, New York. The event was celebrated in the company of Medisca’s valued Plattsburgh team, business partners, and state and federal officials, including Congresswoman Elise […]
LC-Plasma-based Vaccine Research Selected for SCARDA Project
– Towards the Development of a Vaccine to prevent Respiratory Virus Infection – TOKYO–(BUSINESS WIRE)–May. 08, 2024 Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization against infectious diseases. We now announce that a […]
A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer
MONTREAL–(BUSINESS WIRE)–Apr. 17, 2024 Medisca, a global company specializing in personalized pharmaceutical solutions, is pleased to announce the appointment of Sanjay D. Goorachurn as the company’s new CEO, as founders, Tony Dos Santos and Maria Zaccardo, transition into strategic advisory roles as Chair and Vice Chair, respectively. Coinciding with the company’s 35th anniversary, this decision […]
Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation
Agreement spans wide range of Medidata’s solutions to enhance clinical trial efficiency NEW YORK–(BUSINESS WIRE)–Mar. 22, 2024 Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced it has renewed its relationship with the PPD clinical research business of Thermo Fisher Scientific Inc. The agreement features […]
Mitsubishi Corporation Life Sciences Published New Study regarding the Effect of Ingestion of Cysteine Peptide containing Glutathione on Skin Brightness
TOKYO–(BUSINESS WIRE)–Mar. 12, 2024 Mitsubishi Corporation Life Sciences Limited (Head Office: Chiyoda-ku, Tokyo Japan; Koji Kishimoto, representative director and president) conducted the clinical study regarding skin brightness in cysteine peptide and published it in Cosmetics 2023, 10, 72. In this study, Mitsubishi Corporation Life Sciences defined glutathione (GSH), cysteinylglycine (Cys-Gly), and glutamylcysteine (-Glu-Cys) as cysteine […]
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Collaboration will harness Medidata Electronic Clinical Outcome Assessment (eCOA) for remote patient engagement and real-time data capture NEW YORK–(BUSINESS WIRE)–Feb. 06, 2024 Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, and Sanofi Vaccines, today announced a collaboration to harness Medidata eCOA to deploy in vaccine studies. […]
Timeline a Swiss Longevity Biotech Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders including L’Oréal and Nestlé
LAUSANNE, Switzerland–(BUSINESS WIRE)–Jan. 17, 2024 Timeline, a consumer health biotech company at the forefront of developing innovative solutions for healthy aging and longevity, today announces that it raised CHF 56M (USD 66M) in an oversubscribed Series D financing round. This marks a significant milestone for the company and includes strategic investments from two global industry […]
Xenco Medical Unveils the TrabeculeX Continuum a Breakthrough Convergence of Digital Health and Biomaterials at CES 2024 in Las Vegas the World’s Largest Technology Conference
SAN DIEGO–(BUSINESS WIRE)–Jan. 16, 2024 On January 11th, trailblazing medical technology company Xenco Medical unveiled its convergent technology bridging Digital Health and Biomaterials by showcasing its TrabeculeX Continuum™ at the 2024 Consumer Electronics Show in Las Vegas, Nevada. Comprising the FDA-cleared TrabeculeX Bioactive Matrix™ and the TrabeculeX Recovery App™, the TrabeculeX Continuum is the first […]